Chien Tsu-Ming, Chan Ti-Chun, Huang Steven Kuan-Hua, Yeh Bi-Wen, Li Wei-Ming, Huang Chun-Nung, Li Ching-Chia, Wu Wen-Jeng, Li Chien-Feng
Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
Cancers (Basel). 2020 Mar 9;12(3):630. doi: 10.3390/cancers12030630.
We sought to examine the relationship between microtubule-associated proteins (MAPs) and the prognosis of urothelial carcinoma by assessing the microtubule bundle formation genes using a reappraisal transcriptome dataset of urothelial carcinoma (GSE31684). The result revealed that microtubule-associated protein 1b () is the most significant upregulated gene related to cancer progression. Real-time reverse-transcription polymerase chain reaction was used to measure transcription levels in urothelial carcinoma of the upper tract (UTUC) and the bladder (UBUC). Immunohistochemistry was conducted to detect protein expression in 340 UTUC and 295 UBUC cases. Correlations of expression with clinicopathological status, disease-specific survival, and metastasis-free survival were completed. To assess the oncogenic functions of , the RTCC1 and J82 cell lines were stably silenced against their endogenous expression. Study findings indicated that overexpression was associated with adverse clinical features and could independently predict unfavorable prognostic effects, indicating its theranostic value in urothelial carcinoma.
我们试图通过使用尿路上皮癌的重新评估转录组数据集(GSE31684)评估微管束形成基因,来研究微管相关蛋白(MAPs)与尿路上皮癌预后之间的关系。结果显示,微管相关蛋白1b( )是与癌症进展最显著上调的基因。采用实时逆转录聚合酶链反应来测量上尿路尿路上皮癌(UTUC)和膀胱尿路上皮癌(UBUC)中的 转录水平。进行免疫组织化学检测340例UTUC和295例UBUC病例中的 蛋白表达。完成了 表达与临床病理状态、疾病特异性生存和无转移生存的相关性分析。为了评估 的致癌功能,RTCC1和J82细胞系针对其内源性 表达进行了稳定沉默。研究结果表明, 过表达与不良临床特征相关,并且可以独立预测不良预后效应,表明其在尿路上皮癌中的诊疗价值。